JP Morgan Private Wealth Advisors’s BioLife Solutions BLFS Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$154K	Sell	11,186 -2,781	-20%	-$43.8K	﹤0.01%	1655
2023 Q2	$309K	Sell	13,967 -19,259	-58%	-$406K	﹤0.01%	1231
2023 Q1	$723K	Sell	33,226 -218	-0.7%	-$4.9K	﹤0.01%	1320
2022 Q4	$609K	Buy	33,444 +4,929	+17%	+$102K	﹤0.01%	1389
2022 Q3	$649K	Buy	28,515 +4,431	+18%	+$94.8K	﹤0.01%	1345
2022 Q2	$333K	Buy	24,084 +1,705	+8%	+$25K	﹤0.01%	1607
2022 Q1	$509K	Buy	22,379 +589	+3%	+$15.5K	﹤0.01%	1528
2021 Q4	$812K	Buy	21,790 +11,567	+113%	+$496K	﹤0.01%	1343
2021 Q3	$433K	Buy	10,223 +1,173	+13%	+$56.5K	﹤0.01%	1555
2021 Q2	$403K	Buy	9,050 +1,413	+19%	+$49.8K	﹤0.01%	1557
2021 Q1	$275K	Buy	+7,637	New	+$302K	﹤0.01%	1564

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

JP Morgan Private Wealth Advisors's BLFS Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its BioLife Solutions (BLFS) stake by 20% in Q3 2023, selling an estimated $43.8K and leaving 11,186 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

JP Morgan Private Wealth Advisors first reported a position in BLFS in Q1 2021 and has held it in 11 quarters since. The position peaked at $812K in Q4 2021. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

JP Morgan Private Wealth Advisors held 11,186 shares of BioLife Solutions worth $154K as of Q3 2023.
JP Morgan Private Wealth Advisors sold 2,781 BioLife Solutions shares in Q3 2023, an estimated $43.8K.
BioLife Solutions made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1655 holding.
JP Morgan Private Wealth Advisors first reported a position in BioLife Solutions in Q1 2021 and has held it in 11 quarters since.
JP Morgan Private Wealth Advisors's BioLife Solutions position peaked at $812K in Q4 2021.
153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.